China approves Blackstone and TPG acquisition of medical technology firm Hologic
China approved the $18.3 billion buyout of Hologic by Blackstone and TPG on Tuesday. This marks the largest medical device transaction in nearly two decades.
Insights:
The State Administration for Market Regulation in China 
CN has granted approval for the acquisition of medical diagnostics firm Hologic, Inc. by private equity firms Blackstone Inc. and TPG Inc. . The regulatory sign-off, announced on February 10, 2026, represents a key regulatory milestone for the previously announced $18.3 billion take-private transaction.
CN has granted approval for the acquisition of medical diagnostics firm Hologic, Inc. by private equity firms Blackstone Inc. and TPG Inc. . The regulatory sign-off, announced on February 10, 2026, represents a key regulatory milestone for the previously announced $18.3 billion take-private transaction.The transaction has been described as the largest medical devices deal in almost two decades. Because Hologic maintains manufacturing operations and a partnership in China, the approval from the market regulator was relevant to the deal's progress. The State Administration for Market Regulation maintains jurisdiction over foreign companies that possess substantial business or sales within the country, making its clearance a necessary factor for the progression of the $18.3 billion take-private transaction.
